| Issue |
Title |
File |
| Vol 25, No 3 (2023) |
Experience in organizing nutritional support in cancer patients at the Tsyb Medical Radiological Research Centre |
(Rus)
|
|
Potapov A.L., Аgababyan T.A., Dorozhkin A.D., Pimonova I.S., Nevolskikh A.A., Ivanov S.A., Kaprin A.D.
|
| Vol 18, No 3 (2016) |
Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy |
(Rus)
|
|
Vladimirova L.Y., Mitashok I.S., Snezhko T.A., Samaneva N.Y., Storozhakova A.E., Kornilova I.S.
|
| Vol 24, No 3 (2022) |
Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report |
(Rus)
|
|
Semenov E.V., Gasymly D.D., Zyuzyukina A.V., Zukov R.A.
|
| Vol 16, No 3 (2014) |
Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial |
|
|
Ahmetzanov F.S., Ahmetzanova F.F.
|
| Vol 26, No 1 (2024) |
Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study |
(Rus)
|
|
Levashov A. ., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V. ., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadirov S.U., Polyakov V.G.
|
| Vol 26, No 4 (2024) |
Experience of Next-Generation Sequencing in urothelial carcinoma specimens with panel for 523 genes |
(Rus)
|
|
Gridneva Y.V., Khmelkova D.N., Volkova M.I., Blagodatskikh K.A., Zheludkevich A.A., Semenova A.B., Veshchevailov A.A., Babkina A.V., Bondarev S.A., Galkin V.N.
|
| Vol 25, No 2 (2023) |
Experience of surgical treatment of hemangioma of the spleen. A clinical case |
(Rus)
|
|
Chekini A.K., Novikov D.V., Avturkhanov T.M., Mkrtumyan R.A., Novikova A.O.
|
| Vol 23, No 2 (2021) |
Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period |
(Rus)
|
|
Bukharov A.V., Derzhavin V.A., Yadrina A.V., Erin D.A.
|
| Vol 19, No 2 (2017) |
Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0 |
(Rus)
|
|
Manikhas A.G., Grinev I.A., Oganesian A.S., Chikrizov S.I., Manikhas G.M.
|
| Vol 17, No 3 (2015) |
Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors |
|
|
Markovich A.A., Kuzminov A.E., Orel N.F., Odintsova A.S., Emelyanova G.S., Gorbunova V.A.
|
| Vol 15, No 2 (2013) |
Experience with Hyposalix spray treatment for xerostomia |
|
|
Afanasyev V.V., Titova O.N., Ordashev K.A., Ugurchiev Y.S.
|
| Vol 24, No 2 (2022) |
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study |
(Rus)
|
|
Sultanbaev A.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Fatikhova A.A., Izmailov A.A., Lipatov O.N., Ayupov R.T., Sultanbaeva N.I., Menshikova I.A., Serebrennikov G.A.
|
| Vol 25, No 3 (2023) |
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis |
(Rus)
|
|
Lyadova M.A., Fedorinov D.S., Kuzmina E.S., Antonova T.G., Sokolskaya V.K.
|
| Vol 17, No 5 (2015) |
Extranodal non-Hodgkin's lymphomas of the central nervous system, the testis and the pancreas |
|
|
Babicheva L.G.
|
| Vol 23, No 3 (2021) |
Extrapulmonary small cell carcinoma. Literature review |
(Rus)
|
|
Orel N.F., Poddubnaya I.V.
|
| Vol 24, No 1 (2022) |
Factors associated with the degree of 99mTc-MIBI accumulation in parathyroid glands neoplasms during planar scintigraphy and SPECT/CT in primary hyperparathyroidism |
(Rus)
|
|
Slashchuk K.Y., Degtyarev M.V., Rumyantsev P.O., Rebrova O.Y., Elfimova A.R., Selivanova L.S., Mokrysheva N.G.
|
| Vol 7, No 1 (2005) |
Faktory prognoza pri rake molochnoy zhelezy |
|
|
Bozhok A.A., Semiglazov V.F., Semiglazov V.V., Arzumanov A.S., Kletsel' A.E.
|
| Vol 8, No 3 (2006) |
Faktory prognoza v opredelenii ob\"ema operatsii pri differentsirovannom rake shchitovidnoy zhelezy |
|
|
Brzhezovskiy V.Z., Lyubaev V.L., Kochurina G.Y., Subramanian S.
|
| Vol 3, No 3 (2001) |
Farmakoekonomicheskiy analiz "stoimost'-poleznost'" kak kriteriy ekonomicheskoy obosnovannosti ispol'zovaniya byudzhetnykh sredstv v onkologii |
|
|
Poddubnaya I.V., Arkad'eva T.V., Davidenko I.S., Rozenbaum L.A.
|
| Vol 7, No 2 (2005) |
Farmorubitsin v klinicheskoy praktike |
|
|
Gorbunova V.A.
|
| Vol 13, No 2 (2011) |
Fazlodeks: novye vozmozhnostiendokrinoterapii raka molochnoy zhelezy |
|
|
Vysotskaya I.V.
|
| Vol 17, No 4 (2015) |
FDA approves ixazomib in combination with lenalidomide and dexamethasone for multiple myeloma |
|
|
- -.
|
| Vol 17, No 4 (2015) |
FDA approves Opdivo to treat advanced form of kidney cancer |
|
|
- -.
|
| Vol 16, No 4 (2014) |
Features of development of metachronous and synchronous tumors in the population of Belgorod region associated with the consequences of the Chernobyl accident |
|
|
Kovalenko B.S., Golivets T.P., Podvyaznikov S.O.
|
| Vol 22, No 3 (2020) |
Features of management of oncohematological patients in the context of the COVID-19 pandemic |
(Rus)
|
|
Poddubnaya I.V., Tumian G.S., Trofimova O.P., Babicheva L.G., Bariakh E.A., Poliakov A.S.
|
| Vol 23, No 4 (2021) |
Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III |
(Rus)
|
|
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Ganshina I.P., Khokhlova S.V., Kоmetova V.V., Rodionov V.V.
|
| Vol 18, No 1 (2016) |
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy |
(Rus)
|
|
Kolyadina I.V., Poddubnaya I.V., Pavlikova O.A., Komov D.V.
|
| Vol 3, No 1 (2001) |
Febril'nye neytropenii u detey s ostrymi mieloidnymi leykozami |
|
|
Ivanova L.F., Dmitrieva N.V., Popa A.V., Bagirova N.S., Durnov L.A.
|
| Vol 9, No 3 (2007) |
Femara (letrozol) v ad\"yuvantnoy terapii raka molochnoy zhelezy |
|
|
Stenina M.B.
|
| Vol 10, No 2 (2008) |
Femara (letrozol) v sovremennoy terapii raka molochnoy zhelezy |
|
|
Perevodchikova N.I.
|
| Vol 6, No 1 (2004) |
Fibrozno - kistoznaya bolezn' |
|
|
Makarenko N.P., Korzhenkova G.P.
|
| Vol 26, No 1 (2024) |
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia |
(Rus)
|
|
Orlova K.V., Fedyanin M.I., Simanenkov K.E., Dergunov A.S., Goldshmidt P.R., Saydullaeva A.F., Bogacheva D.V., Yavorskaya M.A., Azanov A.Z., Fedenko A.A., Bolotina L.V., Deshkina T.I., Babina K.G., Kuzevanova E.A., Zhukova L.G., Feoktistova P.S., Polshina N.I., Peganova E.V., Shikina V.E., Sobolev M.M., Mironov O.V., Vaschenko V.A., Ershova M.M., Mezhueva A.O., Orlova S.A., Tantsyrev D.A., Taskina D.K., Teterich A.A., Karabina E.V., Kostalanova Y.V., Bogacheva M.V., Zhukova N.V., Orlova R.V., Zinkevich M.V., Kazmin A.I., Volkonskiy M.V., Voronkova L.M., Karpova A.S., Maleyko M.L., Gorshenina M.N., Kryuchkova E.I., Moiseenko F.V., Murzina Y.I., Musin S.I., Ogloblin A.N., Perminova M.S., Dumbrava R.A., Emelyanov S.A., Protsenko S.A., Sultanbaev A.V., Tarasova A.V., Shakhnovich E.B., Demchenkova M.V., Lozovskaya Y.A., Musaeva K.S., Pavlova E.M., Skotnikov R.A., Chernova V.V., Chichkanova A.S., Akhmatova A.M., Zafirova M.A., Mischenko A.A., Ovsienko E.N., Petrukhnenko V.A., Syusyukaylova O.A., Tyugina Y.A., Shumilkina E.A., Stroyakovskiy D.L., Yurchenkov A.N., Baldin P.L., Belova A.S., Diduk O.V., Konovalova E.A., Lebedeva L.N., Li Y.A., Mashtapa V.V., Mironenkova Y.A., Narovenkova K.V., Pavlikova O.A., Parsadanova E.L., Pimonova I.S., Ruzhnikova A.A., Sivunova I.D., Soloveva E.P., Sosnin M.I., Temirsultanova K.T., Tyulegenova M.Z., Khodkevich A.V., Shakurova N.R., Efendieva S.N., Avagimyan K.L., Anokhina E.Р., Antoshkina M.I., Borzyanitsa S.M., Dzhentemirov S.K., Dmitrochenko M.V., Zheleznyak A.V., Komoza Y.V., Kopanev A.S., Kornienko T.I., Krasilnikova M.A., Lukhmanova D.A., Mazur N.S., Markina P.M., Mitapov Z.S., Osodoeva S.N., Prokopenko I.A., Radyukova I.M., Ramazanova M.S., Safarova A.R., Safronova M.A., Khabrieva K.M., Tsygankova N.S., Chermakova K.V., Chirkova T.A., Samoylenko I.V., Nazarova V.V., Akhmetyanova A.E., Demidov L.V.
|
| Vol 26, No 4 (2024) |
First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx |
(Rus)
|
|
Stativko O.A., Pokataev I.A., Kravtsov S.A., Zhukova L.G., Stroyakovskiy D.L., Sabitov E.R., Kuzmina E.S., Feoktistova P.S., Antonova T.G., Lyadova M.A., Nosova M.V., Sydykova R.S., Lisitsyna K.N., Strelnikova T.B., Alizade G.R., Parts S.A., Dolov M.M., Tedeeva A.K., Galkin V.N.
|
| Vol 16, No 2 (2014) |
First results of the Russian multicenter epidemiology project on the malignant gliomas |
|
|
Smolin A.V., Bekyashev A.H., Kobyakov G.L., Sharabura T.M., Mufazalov F.F., Kanischeva N.V., Bumagina V.O.
|
| Vol 22, No 2 (2020) |
First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice |
(Rus)
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 13, No 4 (2011) |
Fludarabin v terapii razlichnykhvariantov nekhodzhkinskikh limfom |
|
|
Bessmel'tsev S.S., Abdulkadyrov K.M.
|
| Vol 22, No 2 (2020) |
Follicular lymphoma |
(Rus)
|
|
Babicheva L.G., Tumyan G.S., Osmanov E.A., Falaleeva N.A., Kravchenko S.K., Stefanov D.N., Poddubnaya I.V., Myakova N.V., Rumyantsev A.G., Maschan A.A., Ptushkin V.V., Baikov V.V., Kovrigina A.M., Krivolapov I.A., Konovalov D.M., Nevolsky A.A., Ivanov S.A., Khaylova Z.V., Gevorkian T.G.
|
| Vol 25, No 1 (2023) |
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review |
(Rus)
|
|
Kolyadina I.V.
|
| Vol 25, No 1 (2023) |
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review |
(Rus)
|
|
Kolyadina I.V.
|
| Vol 24, No 4 (2022) |
Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review |
(Rus)
|
|
Ognerubov N.A.
|
| Vol 14, No 4 (2012) |
Fotodinamicheskaya terapiya pri kombinirovannom lechenii bol'nykh melanomoy kozhi |
|
|
Mogilevskiy I.L., Polsachev V.I., Slovokhodov E.K., Magomedov M.R., Karlova M.A.
|
| Vol 6, No 4 (2004) |
Fragmin v onkologii |
|
|
Ptushkin V.V.
|
| Vol 8, No 1 (2006) |
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom |
|
|
Makarov O.G.
|
| Vol 10, No 1 (2008) |
Fraksiparin v profilaktike tromboticheskikh oslozhneniy u onkoginekologicheskikh bol'nykh |
|
|
Somonova O.V., Madzhuga A.V., Elizarova A.L., Zubrikhina G.N., Kuznetsov V.V.
|
| Vol 24, No 1 (2022) |
From the editor-in-chief of the journal "Modern Oncology" Academician of the Russian Academy of Sciences I.V. Poddubnaya |
(Rus)
|
|
Poddubnaya I.V.
|
| Vol 3, No 4 (2001) |
Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka |
|
|
Manzyuk L.V., Perevodchikova N.I., Gorbunova V.A., Artamonova E.V., Rotobel'skaya L.E., Abramova N.A.
|
| Vol 9, No 1 (2007) |
Ftorafur®. Perspektivy primeneniya v sovremennoy klinicheskoy onkologii |
|
|
Gutorov S.L.
|
| Vol 14, No 3 (2012) |
Fulvestrant - endokrinnaya terapiya rasshirennogo spektra deystviya |
|
|
Meshcheryakov A.A.
|
| Vol 14, No 4 (2012) |
Fulvestrant (Fazlodeks)v dozirovke 500 mg uvelichivaet medianuobshchey vyzhivaemosti na 4,1 mes po sravneniyus dozirovkoy 250 mg |
|
|
- -.
|
| Vol 18, No 4 (2016) |
Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer |
|
|
Vladimirova L.Y.
|
| Vol 9, No 3 (2007) |
Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie |
|
|
Komarova V.P., Komarova L.E., Poddubnaya I.V.
|
| Vol 12, No 4 (2010) |
Fulvestrant vne klinicheskikhissledovaniy (opyt otdeleniya khimioterapii) |
|
|
Voznyy, E.K., Grishunenkova, E.P., Astrakhankina, T.A., Popov, A.Y., Galkin M.M.
|
| Vol 23, No 4 (2021) |
Gastric cancer: Russian clinical guidelines |
(Rus)
|
|
Besova N.S., Kalinin A.E., Nered S.N., Triakin A.A., Gamaiunov S.V., Kozlov N.A., Stilidi I.S., Karachun A.M., Kononets P.V., Malikhova O.A., Riabov A.B., Khomiakov V.M., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Nevol'skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil'mutdinova I.R., Eremushkin M.A., Ivanova G.E., Kondrat'eva K.O., Konchugova T.V., Krutov A.A., Obukhova O.A., Semiglazova T.I., Filonenko E.V., Khulamkhanova M.M., Romanov A.I.
|
| Vol 17, No 2 (2015) |
Gastrointestinal stromal tumors: The 2015 asco News |
|
|
Arkhiri P.P.
|
| Vol 12, No 3 (2010) |
Gastrointestinal'nye stromal'nyeopukholi: obzor materialov ASCO 2010 |
|
|
Nikulin M.P., Stilidi I.S.
|
| Vol 15, No 3 (2013) |
Gefitinib – terapiya vybora 1-y linii nemelkokletochnogo raka legkogo u bol'nykh s nalichiem mutatsiy v gene EGFR |
|
|
Bolotina L.V.
|
| Vol 4, No 1 (2002) |
Geksalen v novykh kombinatsiyakh s gemzarom ili vepezidom pri platino-taksano-rezistentnykh formakh raka yaichnikov |
|
|
Gorbunova V.A., Blyumenberg A.G.
|
| Vol 3, No 2 (2001) |
Gemzar (gemtsitabin) v lechenii nemelkokletochnogo raka legkogo |
|
|
Bychkov M.B., Voznyy E.K., Gorbunova V.A., Marenich A.F.
|
| Vol 6, No 1 (2004) |
Gemzar v kombinatsii s tsisplatinom v terapii infil'trativnykh form raka mochevogo puzyrya |
|
|
Arzumanov A.A., Shkol'nik M.I., Leonenko R.V., Maslyukova E.A., Maslyukova A., Karelin M.I.
|
| Vol 22, No 4 (2020) |
Gene polymorphisms role of blood coagulation in myocardial infarction development in patients with malignant tumors of thoracoabdominal localization |
(Rus)
|
|
Korolyova A.A., Gerasimov S.S., Kononets P.V., Lyubchenko L.N.
|
| Vol 24, No 3 (2022) |
Genetic markers associated with resistance to radioiodine therapy in thyroid cancer patients: Prospective cohort study |
(Rus)
|
|
Denisenko N.P., Shuev G.N., Mukhamadiev R.H., Perfilieva O.M., Kazakov R.E., Kachanova A.A., Milyutina O.I., Konenkova O.V., Ryzhkin S.A., Ivashchenko D.V., Bure I.V., Kirienko S.L., Zhmaeva E.M., Mirzaev K.B., Ametov A.S., Poddubnaya I.V., Sychev D.A.
|
| Vol 3, No 4 (2001) |
Genetika raka zheludochno-kishechnogo trakta |
|
|
Gar'kavtseva R.F., Kazubskaya T.P., Belev N.F., Sel'chuk V.Y.
|
| Vol 25, No 4 (2023) |
Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review |
(Rus)
|
|
Timoshkina N.N., Petrusenko N.A., Gabrichidze P.N., Cherkess M.A., Pushkareva T.F., Savchenko D.A.
|
| Vol 10, No 2 (2008) |
Germinogennye opukholi u bol'nykh SPIDom |
|
|
Pivnik A.V., Seregin N.V., Parkhomenko Y.G., Tishkevich O.A., Kovrigina A.M., Gruzdev B.M., Petrova E.V., Likunov E.B.
|
| Vol 11, No 3 (2009) |
Gertseptin: mekhanizm deystviya |
|
|
Imyanitov E.N.
|
| Vol 5, No 3 (2003) |
Gistologicheskie i gistoimmunokhimicheskie osobennosti uveal'noy melanomy pri pervichno-mnozhestvennom porazhenii i solitarnoy uveal'noy melanome |
|
|
Poddubnaya I.V., Grishina E.E., Lerner M.Y., Nechestnyuk S.Y.
|
| Vol 4, No 1 (2002) |
Glivek - patogeneticheskaya terapiya zlokachestvennykh novoobrazovaniy |
|
|
Meshcheryakov A.A.
|
| Vol 11, No 4 (2009) |
Glivek v ad\"yuvantnoy terapii gastro-intestinal'nykh stromal'nykh opukholey. Novoe pokazanie – novye vozmozhnosti |
|
|
- -.
|
| Vol 10, No 4 (2008) |
Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey |
|
|
Rasner P.I., Pushkar' D.Y., Govorov A.V.
|
| Vol 2, No 3 (2000) |
Gormonoterapiya generalizovannogo raka predstatel'noy zhelezy |
|
|
Rusakov I.G., Alekseev B.Y.
|
| Vol 25, No 1 (2023) |
Guidelines for the endoscopic diagnosis, treatment and follow-up of patients with epithelial neoplasms of the colon. 2022 |
(Rus)
|
|
Malikhova O.A., Zavyalov D.V., Kashin S.V., Shishin K.V., Ilyashenko M.G., Kireev S.U., Mikhin A.I., Sidorova A.N., Malikhov A.G.
|
| Vol 22, No 1 (2020) |
Hairy cell leukemia. Clinical recommendations |
(Rus)
|
|
Al’-Radi L.S., Baikov V.V., Kovrigina A.M., Krivolapov I.A., Moiseeva T.N., Nikitin E.A., Pivnik A.V., Stadnik E.A., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| Vol 19, No 4 (2017) |
Head and neck cutaneous melanoma: an influence of surgical resection margin on long-term results |
(Rus)
|
|
Pak M.B., Mudunov A.M., Demidov L.V., Azizyan R.I., Brzhezovskiy V.Z., Stelmah D.K., Alymov Y.V., Ignatova A.V.
|
| Vol 16, No 3 (2014) |
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment |
|
|
Besova N.S.
|
| Vol 11, No 2 (2009) |
HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy |
|
|
Ognerubova I.N.
|
| Vol 14, No 1 (2012) |
HER2-testirovanie metodamiimmunogistokhimii, fluorestsentnoy(FISH) i khromogennoy (SISH) in situgibridizatsii pri rake zheludkai pishchevodno-zheludochnogo perekhoda |
|
|
Zavalishina L.E., Ryazantseva A.A., Andreeva Y.Y., Frank G.A.
|
| Vol 26, No 1 (2024) |
Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review |
(Rus)
|
|
Sultanbaev A.V., Kolyadina I.V., Gilyazova I.R., Nasretdinov A.F., Musin S.I., Sultanbaeva N.I., Menshikov K.V.
|
| Vol 17, No 3 (2015) |
Hereditary ovarian cancer |
|
|
Demidova I.A.
|
| Vol 25, No 2 (2023) |
Heterogeneous diffuse large B-cell lymphoma: accurate diagnosis as a key to successful therapy. A review |
(Rus)
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 16, No 2 (2014) |
High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study) |
|
|
Seryakov A.P., Ovchinnikova L.K., Zabelin M.V., Yakubov T.Z., Sidorov D.B., Ovchinnikov M.V.
|
| Vol 22, No 2 (2020) |
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience |
(Rus)
|
|
Mochkin N.E., Sarzhevskiy V.O., Dubinina J.N., Smirnova E.G., Fedorenko D.A., Bannikova A.E., Kolesnikova D.S., Bogatyrev V.S., Samoylova A.A., Faddeev N.M., Melnichenko V.Y.
|
| Vol 16, No 1 (2014) |
High-dose chemotherapy with hematopoietic stem cell rescuein children older than 3 year with medulloblastoma: results of single institution trial |
|
|
Babelyan S.S., Subbotina N.N., Dolgopolov I.S., Gorelyshev S.K., Mentkevich G.L., Byarshinov V.K., Pimenov R.I.
|
| Vol 23, No 1 (2021) |
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news |
(Rus)
|
|
Demina E.A.
|
| Vol 22, No 2 (2020) |
Hodgkin's lymphoma |
(Rus)
|
|
Demina E.A., Tumyan G.S., Moiseeva T.N., Mikhailova N.B., Myakova N.V., Rumyantsev A.G., Maschan A.A., Kaplanov K.D., Shmakov R.G., Falaleeva N.A., Ptushkin V.V., Osmanov E.A., Poddubnaya I.V., Baikov V.V., Kovrigina A.M., Konovalov D.M., Trofimova O.P., Sotnikov V.M., Ilin N.V., Vinogradova Y.N., Nechesnyuk A.V., Parkhomenko R.A., Stefanov D.N., Nevolsky A.A., Ivanov S.A., Khaylova Z.V.
|
| Vol 25, No 4 (2023) |
How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review |
(Rus)
|
|
Zhukova L.G., Bordin D.S., Dubtsova E.A., Ilin M.A., Kiriukova M.A., Feoktistova P.S., Egorov V.I.
|
| Vol 21, No 1 (2019) |
HPV-associated lesions in the Russian Federation: assessment of the problem |
(Rus)
|
|
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I.
|
| Vol 25, No 2 (2023) |
Hydroxyethyldimethyldihydropyrimidine as the drug of choice for the prevention of paraprosthetic seromas in breast reconstructive surgery: A retrospective study |
(Rus)
|
|
Khodyrev S.A., Shabaev R.M., Kolyadina I.V., Starokon P.M., Levchuk A.L., Samoylenko V.M.
|
| Vol 25, No 4 (2023) |
Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
(Rus)
|
|
Yudina E.V.
|
| Vol 19, No 2 (2017) |
Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal |
(Rus)
|
|
Glebovskaya V.V., Tkachev S.I., Ivanov S.M., Nazarenko A.V., Rasulov A.O., Gordeev S.S., Bulychkin P.V., Besova N.S., Barsukov U.A., Trofimova O.P., Borisova T.N., Timoshkina E.V.
|
| Vol 22, No 4 (2020) |
Ifosfamide/cyclofosfamide-induced methemoglobinemia in pediatric patients with hemoblastoses |
(Rus)
|
|
Valiev T.T., Korkina Y.S.
|
| Vol 26, No 2 (2024) |
Immediate and long-term outcomes of surgical treatment in patients with retroperitoneal and abdominal desmoid fibromatosis: A retrospective study |
(Rus)
|
|
Turupaev K.A., Budurova M.D., Nikulin M.P.
|
| Vol 23, No 2 (2021) |
Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review |
(Rus)
|
|
Lyadova M.A., Lyadov V.K.
|
| Vol 9, No 1 (2007) |
Immunogistokhimicheskoe opredelenie ekspressii HER2/neu pri rake molochnoy zhelezy (po dannym Smolenskogo oblastnogo onkologicheskogo klinicheskogo dispansera) |
|
|
Shisterova O.A., Golik E.P.
|
| Vol 2, No 4 (2000) |
Immunoglobulinsekretiruyushchaya limfoma iz kletok marginal'noy zony selezenki (kliniko-immunomorfologicheskaya kharakteristika) |
|
|
Gorodetskiy V.R., Probatova N.A., Tupitsyn N.N., Varlamova E.Y., Kondrat'eva T.T., Balakireva T.V., Sholokhova E.N., Saridi E.Y.
|
| Vol 26, No 2 (2024) |
Immunohistochemical factors of prognosis of immunotherapy for metastatic melanoma: А prospective and retrospective study |
(Rus)
|
|
Oganesyan L.V., Zavalishina L.E., Ognerubov N.A., Kostalanova I.V., Orlov A.E., Poddubnaya I.V.
|
| Vol 3, No 2 (2001) |
Immunoliposomy - novoe sredstvo dostavki lekarstvennykh preparatov |
|
|
Baryshnikov A.Y., Oborotova N.A.
|
| Vol 25, No 1 (2023) |
Immunological detection of bone marrow lesions in skin melanoma and its clinical significance: Observational study |
(Rus)
|
|
Krylovetskaya M.A., Chulkova S.V., Markina I.G., Chernysheva O.A., Komarov I.G., Kolbatskaya O.P., Kupryshina N.A., Logachev A.V., Mikhaylova I.N., Demidov L.V., Tupitsyn N.N.
|
| Vol 17, No 1 (2015) |
Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience) |
|
|
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Frank G.A., Komov D.V., Karseladze A.I., Bastiaannet E., Dekker-Ensink N.G.
|
| Vol 26, No 4 (2024) |
Immunological predictors of the therapeutic efficacy of atezolizumab in combination with nab-paclitaxel in metastatic triple-negative breast cancer: A pilot multicenter retrospective associative study |
(Rus)
|
|
Kalinchuk A.Y., Popova N.O., Gofman A.A., Usoltseva I.S., Perelmuter V.M., Tashireva L.A.
|
| Vol 8, No 1 (2006) |
Immuno-morfologicheskie faktory prognoza pri limfome Khodzhkina |
|
|
Tumyan G.S., Tupitsyn N.N., Probatova N.A., Kovrigina A.M., Sholokhova E.N.
|
| 301 - 400 of 1385 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
